Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
Advanced search 
Year : 2022  |  Volume : 18  |  Issue : 78  |  Page : 273-280

Characterization of PLGA-PEG Catharanthus roseus nanoparticles and assessing its anticancer effects in her2-overexpressed breast cancer cells

Department of Biomedical Sciences, Advanced Medical and Dental Institute, [email protected], Universiti Sains Malaysia, 13200 Kepala Batas, Penang, Malaysia

Correspondence Address:
Shahrul Hamid
Advanced Medical and Dental Institute, Universiti Sains Malaysia, 13200 Kepala Batas
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/pm.pm_338_21

Rights and Permissions

Background: Catharanthus roseus (CR) shows promising anticancer activity. However, there is limited information on its polymeric formulation. Objectives: Therefore, current study aimed to characterize poly(lactic-co-glycolic acid (PLGA) CR nanoparticles and determine its effects on resistant human epidermal receptor 2 (HER2)-overexpressed breast cancer cells. Methods: PLGA-polyethylene glycol (PEG) CR nanoparticles were synthesized using the solvent displacement method and characterized using ultraviolet-visible spectroscopy (UV-VIS), Fourier-transform infrared spectroscopy (FTIR), dynamic light scattering, transmission electron microscopy (TEM), zeta potential, encapsulation efficiency, and drug release experiments. Cytotoxicity was done using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay. Protein expression was done with a gel image analyzer. Cell morphological changes were viewed under phase-contrast microscope. Results: TEM images showed the nanoparticles were spherical and size less than 100 nm. FTIR results indicated encapsulation of CR based on the presence of 3327 cm–1, 1637 cm–1, and 1066 cm–1 peaks. Encapsulation efficiency was >60% in both formulations. However, pluronic F68 PLGA-PEG CR nanoparticles showed a gradual release of CR compared with polyvinyl acetate (PVAc). The cytotoxicity assay showed that the half-maximal inhibitory concentration of the CR nanoparticles generated with F68 and PVAc was lower (42–58 μg/mL) on tamoxifen-resistant cells compared with parent cells (99–147 μg/mL). Further analysis using CR nanoparticles with F68 exhibited downregulation of HER2 expression and induced apoptotic features based on morphological changes. Conclusion: These findings suggest that PLGA-PEG nanoparticles could retain the cytotoxic effects of CR.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded25    
    Comments [Add]    

Recommend this journal